| BMP4 |
BMP4, BMP2B, DVR4: Bone morphogenetic protein 4 precursor |
GDF5 |
GDF5, CDMP1: Growth/differentiation factor 5 precursor |
2.43 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
ADAMTSL1 |
IPI00414931 |
2.43 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
CLEC14A |
CLEC14A, C14orf27, UNQ236/PRO269, EGFR5: C-type lectin domain family 14 member A |
2.43 |
Evidence |
|
| COL6A2 |
COL6A2: Collagen alpha-2(VI) chain precursor |
ITIH4 |
ITIH4, IHRP, PRO1851, ITIHL1, PK120: Inter-alpha-trypsin inhibitor heavy chain H |
2.43 |
Evidence |
|
| DMD |
IPI00220577 |
NEFH |
NEFH, KIAA0845, NFH: Neurofilament heavy polypeptide |
2.43 |
Evidence |
|
| LAMC1 |
LAMC1, LAMB2: Laminin subunit gamma-1 precursor |
COL13A1 |
COL13A1: Collagen alpha-1(XIII) chain |
2.43 |
Evidence |
|
| THRA |
THRA, ERBA1, NR1A1, THRA1, THRA2: Thyroid hormone receptor alpha |
NR1H2 |
NR1H2, LXRB, NER, UNR: Oxysterols receptor LXR-beta |
2.43 |
Evidence |
|
| THRA |
THRA, ERBA1, NR1A1, THRA1, THRA2: Thyroid hormone receptor alpha |
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
2.43 |
Evidence |
|
| H2AFZ |
H2AFZ, H2AZ: Histone H2A.Z |
UHRF1 |
|
2.43 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
KLK4 |
KLK4, EMSP1, PRSS17, PSTS: Kallikrein-4 precursor |
2.43 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
DOK6 |
DOK6: Uncharacterized protein DOK6 |
2.43 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
CDC25B |
CDC25B, CDC25HU2: M-phase inducer phosphatase 2 |
2.43 |
Evidence |
|
| CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
HLA-DRB5 |
IPI00107852 |
2.43 |
Evidence |
|
| CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
KIR2DS5 |
KIR2DS5, CD158G, NKAT9: Killer cell immunoglobulin-like receptor 2DS5 precursor |
2.43 |
Evidence |
|
| HTR1A |
HTR1A, ADRB2RL1, ADRBRL1: 5-hydroxytryptamine receptor 1A |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
2.43 |
Evidence |
|
| HTR1A |
HTR1A, ADRB2RL1, ADRBRL1: 5-hydroxytryptamine receptor 1A |
DRD2 |
DRD2: D(2) dopamine receptor |
2.43 |
Evidence |
|
| CD14 |
CD14: Monocyte differentiation antigen CD14 precursor |
TLR10 |
IPI00556077 |
2.43 |
Evidence |
|
| INHBA |
INHBA: Inhibin beta A chain precursor |
C4A |
C4A: Complement C4-A precursor |
2.43 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
TNFRSF19 |
TNFRSF19, TAJ, UNQ1888/PRO4333, TROY: Tumor necrosis factor receptor superfamily |
2.43 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
CD40 |
CD40, TNFRSF5: Tumor necrosis factor receptor superfamily member 5 precursor |
2.43 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
PCDHGB4 |
IPI00028619 |
2.43 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
HLA-DRB5 |
IPI00107852 |
2.43 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
LRFN5 |
LRFN5, C14orf146: Leucine-rich repeat and fibronectin type-III domain-containing |
2.43 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
KIR2DS5 |
KIR2DS5, CD158G, NKAT9: Killer cell immunoglobulin-like receptor 2DS5 precursor |
2.43 |
Evidence |
|
| PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
ADAMTS19 |
ADAMTS19: ADAMTS-19 precursor |
2.43 |
Evidence |
|